대한안과학회 학술대회 발표 연제 초록
 
발표일자: 2016년 11월 4일(금) ~ 11월 6일(일)
발표번호: P(e-poster)-133
발표장소: 킨텍스 제2전시장 7B홀
안구 베체트병에서 양안 유리체강내 오저덱스 주입술의 장기 임상 결과
한길안과병원
손지성, 황덕진
본문 : Purpose To report of a case of bilateral OZURDEX® (dexamethasone intravitreal implant) injections in a patient with bilateral ocular Behcet attack. Case Report A 27-year-old woman came to clinic with sudden deceased vision of left eye. She has been suffered from recurrent ocular Bechet attack twice on right eye over 3 years. She has received intravitreal bevacizumab injection for the 1st attack 2 years ago and received Intravitreal OZURDEX® injection for the 2nd attack 8 months after the initial attack. Her right eye presented stable clinical course over 14 months after the 2 second injection. The visual acuity of her left eye was 20/40, marked macular edema with retinal hemorrhage was observed on fundus examination. Intravitreal OZURDEX® was performed on her left eye. Visual acuity and macular structure was normalized within 2 months, remained stable for over 1 year of clinical follow up. At final clinical visit, visual acuity was 20/20 bilaterally without any evidence of recurrent ocular Behcet attack. Conclusions The prompt and timely intervention with OZURDEX® (dexamethasone intravitreal implant) injection can be an useful rescue treatment with the reliable long term efficacy in a patient with recurrent ocular Behcet attack on both eyes.
 
[돌아가기]